MFG
OGN icon

Menard Financial Group’s Organon & Co OGN Stock Holding History

Menard Financial Group’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30
Closed -$448 – 245
2024
Q4 		$448 Buy
+30
New +$489 ﹤0.01% 307

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.66B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Menard Financial Group's OGN Position: Q1 2025 in Review

Menard Financial Group sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 30 shares — an estimated $448 sold.

Menard Financial Group first reported a position in OGN in Q4 2024 and held it in 1 quarter. The position peaked at $448 in Q4 2024. 721 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Menard Financial Group reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Menard Financial Group sold 30 Organon & Co shares in Q1 2025, an estimated $448.
  • Menard Financial Group first reported a position in Organon & Co in Q4 2024 and held it in 1 quarter.
  • Menard Financial Group's Organon & Co position peaked at $448 in Q4 2024.
  • 721 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Menard Financial Group's 13F filing for Q1 2025, filed 8 May 2025.